Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP723923.RAk2H6-sciltraggkMq6La_nl53PjTJ9of1EbWKXEdSLQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP723923.RAk2H6-sciltraggkMq6La_nl53PjTJ9of1EbWKXEdSLQ130_assertion type Assertion NP723923.RAk2H6-sciltraggkMq6La_nl53PjTJ9of1EbWKXEdSLQ130_head.
- NP723923.RAk2H6-sciltraggkMq6La_nl53PjTJ9of1EbWKXEdSLQ130_assertion description "[Whole-tissue sections of 309 tumors were evaluated: 49 LGFMSs (all with FUS gene rearrangement confirmed by fluorescence in situ hybridization), 40 soft tissue perineuriomas, 40 myxofibrosarcomas, 20 cellular myxomas, 20 solitary fibrous tumors, 20 low-grade malignant peripheral nerve sheath tumors, 20 cases of desmoid fibromatosis, 20 neurofibromas, 20 schwannomas, 20 monophasic synovial sarcomas, 20 cases of dermatofibrosarcoma protuberans, 10 myxoid liposarcomas, and 10 extraskeletal myxoid chondrosarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP723923.RAk2H6-sciltraggkMq6La_nl53PjTJ9of1EbWKXEdSLQ130_provenance.
- NP723923.RAk2H6-sciltraggkMq6La_nl53PjTJ9of1EbWKXEdSLQ130_assertion evidence source_evidence_literature NP723923.RAk2H6-sciltraggkMq6La_nl53PjTJ9of1EbWKXEdSLQ130_provenance.
- NP723923.RAk2H6-sciltraggkMq6La_nl53PjTJ9of1EbWKXEdSLQ130_assertion SIO_000772 21415703 NP723923.RAk2H6-sciltraggkMq6La_nl53PjTJ9of1EbWKXEdSLQ130_provenance.
- NP723923.RAk2H6-sciltraggkMq6La_nl53PjTJ9of1EbWKXEdSLQ130_assertion wasDerivedFrom befree-20140225 NP723923.RAk2H6-sciltraggkMq6La_nl53PjTJ9of1EbWKXEdSLQ130_provenance.
- NP723923.RAk2H6-sciltraggkMq6La_nl53PjTJ9of1EbWKXEdSLQ130_assertion wasGeneratedBy ECO_0000203 NP723923.RAk2H6-sciltraggkMq6La_nl53PjTJ9of1EbWKXEdSLQ130_provenance.